Xylem Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B |
| Gross profit | $3.5B | $3.2B | $2.7B | $2.1B | $2.0B |
| Operating income | $1.2B | $1.0B | $652.0M | $622.0M | $585.0M |
| Cost of revenue | $5.6B | $5.3B | $4.6B | $3.4B | $3.2B |
| Cash from operations | $1.2B | $1.3B | $837.0M | $596.0M | $538.0M |
| Capital expenditure | $331.0M | $321.0M | $271.0M | $208.0M | $208.0M |
| Free cash flow | $910.0M | $942.0M | $566.0M | $388.0M | $330.0M |
| Share repurchases | $15.0M | $20.0M | $25.0M | $52.0M | $68.0M |
| Impairments | $8.0M | $7.0M | $4.0M | $14.0M | $1.0M |
| Total assets | $17.6B | $16.5B | $16.1B | $8.0B | $8.3B |
| Total liabilities | $5.9B | $5.6B | $5.9B | $4.4B | $5.0B |
| Total debt | $1.9B | $2.0B | $2.3B | $1.9B | $2.4B |
Shares outstanding 237.7M · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.
Recent filings
- May 29, 2026 8-K
- May 18, 2026 8-K
- April 28, 2026 10-Q
- April 28, 2026 8-K
- February 25, 2026 8-K
- February 25, 2026 10-K
- February 10, 2026 8-K
- October 28, 2025 10-Q